biology

Pegunigalsidase alfa

Pegunigalsidase alfa is a biology topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Pegunigalsidase alfa rather than just read about it. In short: Pegunigalsidase alfa, sold under the brand name Elfabrio, is an enzyme replacement therapy for the treatment of Fabry disease. It is a recombinant human α-galactosidase-A.

Key takeaways

Pegunigalsidase alfa belongs to biology; place it in that map before memorising details.
Learn the definition first, then one example that makes the definition concrete.
Connect Pegunigalsidase alfa to a quantity you can measure, compute or draw — that is where exam questions come from.
Reproduce the core statement of Pegunigalsidase alfa from memory before moving on to harder problems.

Reference excerpt

Pegunigalsidase alfa, sold under the brand name Elfabrio, is an enzyme replacement therapy for the treatment of Fabry disease. It is a recombinant human α-galactosidase-A. It is a hydrolytic lysosomal neutral glycosphingolipid-specific enzyme. The most common side effects are infusion-related reactions, hypersensitivity and asthenia. Pegunigalsidase alfa was approved for medical use in both the European Union and the United States in May 2023.

Medical uses Pegunigalsidase alfa is indicated for long-term enzyme replacement therapy in adults with a confirmed diagnosis of Fabry disease (deficiency of alpha-galactosidase).

Society and culture

Legal status In February 2023, the Committee for Medicinal Products for Human Use of the European Medicines Agency adopted a positive opinion, recommending the granting of a marketing authorization for the medicinal product Elfabrio, intended for the treatment of Fabry disease. The applicant for this medicinal product is Chiesi Farmaceutici S.p.A. Elfabrio was approved for medical use in the European Union in May 2023.

References

Further reading Schiffmann R, Goker-Alpan O, Holida M, Giraldo P, Barisoni L, Colvin RB, et al. (May 2019). "Pegunigalsidase alfa, a novel PEGylated enzyme replacement therapy for Fabry disease, provides sustained plasma concentrations and favorable pharmacodynamics: A 1-year Phase 1/2 clinical trial". Journal of Inherited Metabolic Disease. 42 (3): 534–544. doi:10.1002/jimd.12080. PMID 30834538. S2CID 73489645.

Worked examples

Example 1 — a first encounter with Pegunigalsidase alfa

Start with the simplest possible case. Write down what Pegunigalsidase alfa claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In biology, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Pegunigalsidase alfa before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Pegunigalsidase alfa ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Pegunigalsidase alfa

In research: Pegunigalsidase alfa appears in biology research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry: Engineering practice reuses Pegunigalsidase alfa in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom: Pegunigalsidase alfa is common in secondary-school and first-year university syllabi. It links to neighbouring topics Drugs acting on the gastrointestinal system and metabolism, Medical treatments, Orphan drugs, so understanding it makes those chapters shorter.
In everyday life: Look for Pegunigalsidase alfa outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Pegunigalsidase alfa” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Pegunigalsidase alfa in 20 minutes

Read the reference excerpt below once, without taking notes.
Close the page and write down what Pegunigalsidase alfa means in your own words.
Compare your version with the excerpt and mark what you missed.
Work through the three examples above with pen and paper.
Explain Pegunigalsidase alfa out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Pegunigalsidase alfa in simple terms?

Pegunigalsidase alfa, sold under the brand name Elfabrio, is an enzyme replacement therapy for the treatment of Fabry disease. It is a recombinant human α-galactosidase-A.

Why does Pegunigalsidase alfa matter?

Because it connects several biology ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Pegunigalsidase alfa?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Pegunigalsidase alfa.